Search details
1.
Real-world effectiveness and safety of daratumumab, bortezomib and dexamethasone in relapsed/refractory multiple myeloma in Slovakia.
Neoplasma
; 68(3): 626-630, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33567854
2.
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.
Haematologica
; 106(2): 601-604, 2021 02 01.
Article
in English
| MEDLINE | ID: mdl-32381580
3.
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.
Cancers (Basel)
; 14(20)2022 Oct 21.
Article
in English
| MEDLINE | ID: mdl-36291949
4.
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.
Blood Adv
; 6(2): 368-372, 2022 01 25.
Article
in English
| MEDLINE | ID: mdl-34500459
Results
1 -
4
de 4
1
Next >
>>